Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

10x Genomics Q1 2024 GAAP EPS $(0.50) Misses $(0.48) Estimate, Sales $141.006M Miss $142.245M Estimate

Author: Benzinga Newsdesk | April 30, 2024 04:11pm

10x Genomics (NASDAQ:TXG) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.48) by 4.17 percent. This is a 13.64 percent decrease over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $141.006 million which missed the analyst consensus estimate of $142.245 million by 0.87 percent. This is a 5.01 percent increase over sales of $134.285 million the same period last year.

Posted In: TXG